CYP inhbitors
CYP1A2 [HSA:1544]
CYP2A6 [HSA:1548]
CYP2B6 [HSA:1555]
CYP2C8 [HSA:1558]
CYP2C9 [HSA:1559]
Amiodarone [DG:DG00204]
Moderate (in vivo)
Benzbromarone
Bucolome
Capecitabine
Weak (in vivo)
Carmofur
Cimetidine [DG:DG00017]
Choline fenofibrate
Cotrimoxazole
Croconazole
Ciclosporin
Delavirdine [DG:DG00662]
Diosmin
Disulfiram
Doxifluridine
Lovastatin
Fenofibrate
Etravirine
Fluconazole [DG:DG00371]
Fluorouracil [DG:DG00687]
Fluvastatin [DG:DG00354]
Fluvoxamine [DG:DG00946]
Isoconazole [DG:DG00365]
Isoniazid [DG:DG00642]
Lanoconazole
D01092 Lanoconazole (JAN/INN)
Leflunomide
Miconazole [DG:DG00004]
Metronidazole
Neticonazole
Oxandrolone
Oxiconazole [DG:DG00367]
Phenylbutazone [DG:DG00745]
Probenecid
Sertraline [DG:DG00945]
Sulconazole [DG:DG00366]
Sulfinpyrazone
Stiripentol
Sulfamethoxazole
Sulfaphenazole
Teniposide
Tegafur
Tigecycline
Tienilic acid
Voriconazole
Zafirlukast
CYP2C19 [HSA:1557]
CYP2D6 [HSA:1565]
CYP3A4 [HSA:1576]
CYP3A5 [HSA:1577]
CYP3A7 [HSA:1551]
CYP3A [HSA:1576 1577 1551]
CYP17 [HSA:1586]
CYP inducers
CYP substrates
Transporter inhibitors
Transporter inducers
Transporter substrates
Drug interactions with metabolizing enzymes and transporters